Insider Trading & Ownership of ARCH Venture Partners IX, LLC

Location: Chicago, IL
Summary: The estimated value of insider holdings of ARCH Venture Partners IX, LLC is at least $86,612,350 dollars as of 29 Jul 2025. ARCH Venture Partners IX, LLC is the 10%+ Owner of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $77.93M. ARCH Venture Partners IX, LLC is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $8.54M. ARCH Venture Partners IX, LLC is the 10%+ Owner of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $140.3K.
Signature: ARCH Venture Partners IX, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Robert Nelsen, Managing Director
All Insider Reports: All Insider Reports

Notify me when ARCH Venture Partners IX, LLC files a new Insider Trading report.

Ownership of ARCH Venture Partners IX, LLC

Symbol	Company	Relationship	Holdings Value	Report Period
BEAM	Beam Therapeutics Inc.	10%+ Owner	$77,929,225	30 Jun 2021
LYEL	Lyell Immunopharma, Inc.	10%+ Owner	$8,542,778	25 Jul 2025
VIR	Vir Biotechnology, Inc.	10%+ Owner	$140,347	02 Sep 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.